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Abstract
Background: During limb development, chondrocytes and osteoblasts emerge from condensations of limb bud
mesenchyme. These cells then proliferate and differentiate in separate but adjacent compartments and function
cooperatively to promote bone growth through the process of endochondral ossification. While many aspects of limb
skeletal formation are understood, little is known about the mechanisms that link the development of undifferentiated limb
bud mesenchyme with formation of the precartilaginous condensation and subsequent proliferative expansion of
chondrocyte and osteoblast lineages. The aim of this study was to gain insight into these processes by examining the roles
of c-Myc and N-Myc in morphogenesis of the limb skeleton.
Methodology/Principal Findings: To investigate c-Myc function in skeletal development, we characterized mice in which
floxed c-Myc alleles were deleted in undifferentiated limb bud mesenchyme with Prx1-Cre, in chondro-osteoprogenitors
with Sox9-Cre and in osteoblasts with Osx1-Cre. We show that c-Myc promotes the proliferative expansion of both
chondrocytes and osteoblasts and as a consequence controls the process of endochondral growth and ossification and
determines bone size. The control of proliferation by c-Myc was related to its effects on global gene transcription, as
phosphorylation of the C-Terminal Domain (pCTD) of RNA Polymerase II, a marker of general transcription initiation, was
tightly coupled to cell proliferation of growth plate chondrocytes where c-Myc is expressed and severely downregulated in
the absence of c-Myc. Finally, we show that combined deletion of N-Myc and c-Myc in early limb bud mesenchyme gives rise
to a severely hypoplastic limb skeleton that exhibits features characteristic of individual c-Myc and N-Myc mutants.
Conclusions/Significance: Our results show that N-Myc and c-Myc act sequentially during limb development to coordinate
the expansion of key progenitor populations responsible for forming the limb skeleton.
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Introduction
The limb skeleton develops from limb buds that are initially
composed of rapidly proliferating multipotent mesenchymal stem
cells encased in ectoderm. These cells are maintained in a
proliferative and undifferentiated state primarily by the secretion
of Fgf and Wnt ligands from ectoderm [1,2]. As the limb bud
expands, centrally located cells begin to condense and their
increasing distance from surface ectoderm-derived proliferative
signals corresponds to their exit from the cell cycle [3]. From
condensing mesenchyme emerge progenitors of chondrogenic,
osteogenic, tendon, ligament and other connective tissues lineages
[4,5,6,3]. Further outgrowth of the limb skeleton is governed
largely by the coordinated homeostatic expansion and differenti-
ation of chondrocytes within the longitudinally oriented structure
known as the growth plate, and osteoblasts in immediately
adjacent perichondrial tissue [7,8]. During bone growth a subset
of slowly proliferating chondrocyte progenitors within the growth
plate continuously enter into a program of terminal differentiation,
where they first undergo proliferative expansion and then undergo
hypertrophy and die. The extracellular matrix laid down by
terminally differentiated chondrocytes serves as a template for
invasion of blood vessels, which in turn serve as a conduit for the
emigration of osteoblasts from their perichondrial residence onto
the cartilaginous template. The dying chondrocytes and invading
osteoblasts establish the ossification front where differentiating
osteoblasts then promote bone mineralization and ossification in
the process of endochondral ossification.
Chondrogenic and osteogenic lineages arising from condensing
mesenchyme in the limb bud are defined by the expression and
activity of the transcription factors Sox9 and Runx2/Cbfa1
respectively [8]. Sox9 regulates a variety of genes encoding
extracellular matrix components that guide chondrocyte behavior
and function, and its deletion prior to condensation in the limb
bud completely blocks cartilage formation [9,10]. In contrast to
Sox9, deletion of Runx2 completely blocks development of the
osteoblast lineage and therefore bone ossification [11,12,13]. Sox9
deletion in the early limb bud also blocks Runx2 expression and
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condensing mesenchyme of the limb bud that fails to properly
form in the absence of Sox9 [10]. Furthermore, Sox9 controls this
early step in osteochondro-progenitor cell fate determination by
directly interacting with Runx2 and inhibiting Runx2 transcrip-
tional activity and its ability to promote osteogenesis [14].
Runx2 is not only a cell autonomous regulator of the osteogenic
lineage, but also has cell non-autonomous effects on osteoblasts by
promoting chondrocyte maturation and expression of Vegfa in
prehypertrophic chondrocytes [15,16]. Vegfa produced in the
prehypertrophic chondrocytes in turn acts on endothelial cells
outsidethe cartilage to direct vascular recruitment and invasion into
the matrix formed by terminally differentiating chondrocytes at the
ossification front [16,17,18,19,20]. Like Runx2, Indian Hedgehog (Ihh)
expression is also initiated in prehypertrophic chondrocytes and Ihh
appears to have a positive influence on blood vessel development or
function [21,22]. Ihh secreted from prehypertrophic chondrocytes
also has a more well-characterized role in governing proliferation of
chondrocytes in the growth plate, as well as osteoblasts in the
perichondrium, by binding to its receptor Patched-1 (Ptch-1) at
these locations and by stimulating production of Parathyroid
hormone-related peptide (PTHrP) [8]. Thus, chondrocyte matura-
tion directed by Runx2 and IHH indirectly influences osteoblast
proliferation to promote endochondral ossification.
Despite major advances in the understanding of chondrocyte and
osteoblast lineage determination and endochondral growth, little is
known about the mechanisms that link the development of
undifferentiated limb bud mesenchyme with formation of the
precartilaginous condensation and subsequent development and
expansion of chondrocyte and osteoblast lineages. Potential
candidates for coordinating these activities are Myc family
transcription factors, particularly c-Myc and N-Myc, which are
known to strongly influence the development and maintenance of
pluripotent and multipotent in a number of homeostatic tissues
(reviewed in [23,24]). N-Myc and c-Myc are sequentially expressed in
developing limbs, with N-Myc expressed primarily in undifferenti-
ated limb bud mesenchyme and c-Myc expressed in proliferating
chondrocytes of the growth plate and osteoblasts in the perichon-
drium (see below). N-Myc is known to promote the proliferative
expansion of undifferentiated limb bud mesenchyme, which in turn
influences the formation of condensing mesenchyme and produc-
tion of osteochondro-progenitors [25,3]. In contrast, c-Myc has
been implicated in the control of chondrocyte proliferation and
differentiation in the growth plate [26,27,28,29], but its effects on
cartilage formation and endochondral ossification are poorly
defined. Using conditional deletion mutants, we show here that c-
Myc plays an important role in endochondral ossification and bone
growth by promoting efficient proliferative expansion of both
chondrocyte and osteoblast lineages. Consistent with N-Myc and c-
Myc playing unique and complementary roles in limb skeletal
development, combined deletion of N-Myc and c-Myc in the early
limb bud gives rise to a severe limb miniaturization phenotype that
exhibits features characteristic of individual c-Myc and N-Myc
mutants. Together, our results indicate that N-Myc and c-Myc
function to maintain and expand distinct and sequentially formed
progenitor populations responsible for forming the limb skeleton.
Results
c-Myc does not influence limb bud outgrowth, but
controls the initial growth of the limb skeleton
To investigate the role of c-Myc in limb development, c-Myc
conditional alleles [30] were deleted with Prx1-Cre, which is active
in undifferentiated limb bud mesenchyme prior to formation of
Sox9-dependent cartilage [31,10]. At E10.5, c-Myc is expressed at
the base of the forelimb bud (Fig. 1A) in a region near to where
Sox9 is expressed (see Fig. 2A–B’), but not in undifferentiated limb
bud mesenchyme. At E11.5 c-Myc is expressed most intensely in a
ring of tissue in the central/proximal limb bud (Fig. 1B) that
appears to surround and perhaps partly overlap with the
expression domains of both Sox9 and Runx2 (Fig. 2C and
Fig. 2G respectively). At E12.5, in addition to a ring pattern of
expression in the more proximal limb region (Fig. 1C) that
overlaps Runx2 expression (Fig. 2H), c-Myc is visible in the initial
cartilage templates of the autopod (Fig. 1C). At E13.5 c-Myc is
expressed in both chondrocytes of cartilage anlage and perichon-
drium where osteoblasts reside (Fig. 1C). Consistent with early and
robust Prx1-Cre activity in limb bud mesenchyme that precedes
Sox9 expression [5,31], c-Myc expression is extinguished in E10.5
and E12.5 limb buds of Prx1-Cre c-Myc
fl/fl (c-Myc cko) mice and in
chondrocyctes and perichondrial cells at E13.5 (Fig. 1A’, B’, C’).
The residual proximal limb bud c-Myc expression observed in c-
Myc cko limb buds at E12.5 is likely in non-targeted muscle cells
streaming into the limb buds since c-Myc expression is apparent in
muscle cells at later stages (not shown).
Consistent with c-Myc playing a role in development of the initial
cartilage template of the limb skeleton, Alcian blue staining at E13.5
revealed a reduction in the size of all limb skeletal elements
(Fig. 1F,G), including the elements of the shoulder (scapula) and
hindlimb girdle (ilium and ishium), which do not develop from
mesenchyme within the limb bud proper [31]. The scapula, which
develops from the somatopleure of the forelimb field (cranial part of
the scapula that articulates with the humerus) and somitic
dermomytome (scapula blade) [31], was more affected than the
illium/ishium, a result consistent with Prx1-Cre being more active in
the emerging forelimb bud and surrounding limb field than
comparable regions of the developing hindlimb bud [10,32].
To examine the relationship between the decreased size of the
cartilaginous elements and cell proliferation, BrdU incorporation
assays performed at E11.5 and E13.5 (Fig. 1H, I). Whereas no
consistent change in the pattern of BrdU incorporation was
evident at E11.5, there was a strong reduction in BrdU
incorporation in both chondrocytes of the emerging growth plate
and in perichondrial cells at E13.5 (Fig. 1H, I, J).
Sox9 and Runx2 expression in the developing limb
skeleton are disrupted by c-Myc-deficiency
To further evaluate how c-Myc deletion influenced chondrocyte
and osteoblast development in the developing limb, Sox9 and
Runx2 expression was examined. At E10.5, c-Myc mutants
consistently showed upregulation and/or expanded expression of
Sox9 (Fig. 2A–B’ also see Fig. 7IV–J), which marks the
precartilaginous condensation. Sox9 expression was similarly
upregulated/expanded in hindlimb buds at E11.5 (not shown), a
developmental stage roughly equivalent to E10.5 in forelimb buds.
In contrast, mutant forelimb buds at E11.5 consistently exhibited
reduced intensity and area of Sox9 expression compared to Prx1-
Cre controls (Fig. 2C, C’). Sox9 expression at E12.5, now marking
the cartilage template of the developing limb skeleton, remained
weak in c-Myc mutants (Fig. 2D, D’).
Runx2, encoding the master regulator of the osteoblast lineage,
was expressed in lateral plate mesoderm adjacent to the emerging
forelimb bud at E10.5 as previously described [5], and Runx2
expression in this region appeared to not be appreciably altered by
Prx1-Cre deletion of c-Myc (Fig. 2G, G’). At E11.5 and E12.5, the
initial Runx2 expression domains in forelimb bud mesenchyme
(Fig. 2H–I’), which partially overlap Sox9 expression (Fig. 2C, D,
also see [5], were reduced in c-Myc mutants. These results suggest
c-Myc and N-Myc in Limb Skeletal Development
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inefficient expansion of the chondrocyte and osteoblast lineages.
Control of endochondral bone growth and ossification
by c-Myc
At E15.5 the coordinated actions of chondrocytes within the growth
plate and osteoblasts in the perichondrium initiate the process of
endochondral ossification. Alcian blue staining of skeletons at E15.5
and E18.5 showed c-Myc mutant elements continued to be reduced in
size and exhibited small primary ossification centers (Fig. 3A–D),
consistent with delayed and/or defective endochondral ossification.
von Kossa staining (mineralized bone) at E15.5 confirmed a delay in
forming the primary ossification center (not shown) At postnatal day 7,
tibias were small but fully ossified (Fig. 3E). Measurements of bone
length at E18.5 showed a similar reduction in the size of all
appendicular elements, with the scapula most affected (Fig. 3F).
Figure 1. c-Myc plays an early role in appendicular skeletal development. (A–C’) Whole mount in situ hybridization of c-Myc in forelimb
buds at E10.5, E11.5 and E12.5 of wildtype and Prx1-Cre c-Myc mutant embryos. (D, D’) In situ hybridization for c-Myc in sections of proximal tibia at
E13.5 of wildtype and Prx1-Cre c-Myc mutant embryos. (E, E’) Higher magnification views of proximal tibia sections shown in D and D’. Cartilage and
(C) and perichondrium (P) are indicated. (H, I) BrdU staining in limb buds at E11.5 and proximal tibia at E13.5 respectively. (J) Summary of BrdU-
positive cells in the proliferative zone (PZ) and perichondrium (Pc).
doi:10.1371/journal.pone.0018795.g001
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to after formation of chondro-osteoprogenitors
Although c-Myc appears to not be expressed in undifferentiated
limb bud mesenchyme (Fig. 1A, B), to rule out that the effects on
Sox9 and Runx2 expression and the small skeleton produced by
Prx1-Cre deletion of c-Myc might be due to cryptic c-Myc activity in
early undifferentiated limb bud mesenchyme, we deleted c-Myc
with Sox9-Cre, which is not active prior to development of
chondro-osteoprogenitors and the precartilaginous condensation
[5]. Sox9-Cre deletion of c-Myc resulted in small limb skeletal
elements with delayed and small primary ossification centers (Fig.
S1), a phenotype essentially identical to that caused by Prx1-Cre
deletion. These results indicate that the function of c-Myc in
appendicular skeletal development is largely, if not wholly,
restricted to after formation of chondro-osteoprogenitors.
In addition, deletion of c-Myc with Osx1-Cre, which is active in
osteoblasts after Runx2-dependent commitment to the osteoblast
lineage [33], had no apparent effect on endochondral ossification
or bone growth (Fig. S2). The latter results suggest that either c-
Myc functions at a relatively early step(s) in osteoblast develop-
ment that is prior to the role Osterix plays in osteoblast
differentiation [34] or that it does not directly regulate osteoblasts
(see Discussion).
c-Myc controls the number of differentiated
chondrocytes produced in the growth plate
Differentiated chondrocytes play critical roles in endochondral
ossification by producing factors such as Vegfa and IHH that
signal to osteoblasts in adjacent perichondrium. Analysis of BrdU
incorporation at E16.5, when endochondral ossification has
commenced, revealed a continued diminution of proliferation
(Fig. 4A, B). Very similar results were observed with c-Myc
deficient tibias at E18.5 (not shown). In addition to decreased
proliferation in the proliferative zone of the growth plate, there
appeared to be lower levels of proliferation in the epiphyseal
articulating surface (Fig. 4A, see arrows), suggesting that c-Myc
may play a role in the development of articular cartilage.
The decreased chondrocyte proliferation in the growth plate
corresponded to a significant decrease in the density of cells in the
proliferative and hypertrophic zones of c-Myc deficient growth
plates as determined by counting DAPI-positive cells (Fig. 4C, E).
The reduced cell density caused by loss of c-Myc is associated with
an increased abundance of Collagen Type 2a1 (Col2) in the
extracellular matrix. An even greater decrease in cell density was
observed in the hypertrophic region marked by Collagen Type X
(ColX) (Fig. 4D, E). In contrast to the prehypertrophic and
hypertrophic regions of the growth plate, the cell density and
already low level of proliferation in the resting zone of proximal
tibias was much less affected by loss of c-Myc (Fig. 4A and not
shown). These results support a role for c-Myc in initiating and
promoting the proliferative expansion of chondrocytes in the
growth plate. The decrease in proliferation and in Runx2
expression in the perichondrium also suggests that c-Myc regulates
expansion of osteoblasts, but the less-well defined architecture of
the perichondrium compared to the growth plate is not amenable
to an accurate determination of how loss of c-Myc might affect cell
density at this location.
Figure 2. Limb bud deletion of c-Myc affects Sox9 and Runx2 expression and formation of cartilage anlage. Analysis of Sox9 expression
(A-D’) and Runx2 expression (E-G’) by in situ hybridization in forelimbs of Prx1-Cre control and c-Myc cko embryos at the indicated stages. Dashed
lines delineate the limb bud. (H, H’) Alcian blue staining of forelimb and hindlinb cartilage anlage of control and c-Myc cko embryos at E13.5.
doi:10.1371/journal.pone.0018795.g002
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decreased Vegfa expression and disrupted
vasculogenesis
To further characterize endochondral growth and ossification in
c-Myc mutants, we examined the relationship between ColX
protein expression in hypertrophic chondrocytes of the growth
plate and Collagen type I (Col1) mRNA expression in osteoblasts. In
E18.5 tibias, the area of hypertrophic ColX expression was
reduced, but what was more striking was a marked decrease in
Col1 expression in perichondrium and bone collar regions as well
as in the primary ossification center (Fig. 5A, B). The osteoblast
marker Osteocalcin was strongly reduced in the same regions (not
shown). In addition, Runx2 expression in perichondrium was
reduced at E18.5 (Fig. 5C), suggesting that osteoblastogenesis is
compromised in c-Myc mutants.
Runx2 expression was also reduced in the growth plate (Fig. 5C
and also see Fig. 9IIG). Because Vegfa expression in the growth
plate is dependent on Runx2 [16], we examined Vegfa in control
and mutant tibias. Both the number of cells expressing Vegfa in
hypertrophic chondrocytes and the intensity of it’s expression was
reduced in the absence of c-Myc (Fig. 5D). Consistent with reduced
expression of Vegfa, blood vessel formation, as marked by
expression of PECAM (CD31) was markedly decreased in the
perichondrium and ossification front of c-Myc mutant tibias
(Fig. 5E), but not in adjacent non-skeletal tissues (data not shown).
These results suggest that the decreased number of osteocytes
within the primary ossification center and the delayed and
defective endochondral ossification observed in c-Myc mutants
may be partly due to defects in vascularization.
Another potential mechanism by which c-Myc might influence
the number of differentiated chondrocytes in the growth plate and
endochondral ossification is defective apoptosis. However, c-Myc
deficiency caused no increase in apoptosis as measured by
TUNEL staining and Lysotracker staining in the growth plate or
perichondrium of tibias at E15.5 or E18.5 (Fig. 5F and not shown).
Expression of key regulators of chondrocyte proliferation
and endochondral ossification in the absence of c-Myc
The reduced number of chondrocytes in proliferative and
hypertrophic zones of c-Myc deficient growth plates, along with
reduced numbers of Col1-, osteocalcin-a n dRunx2-positive osteo-
blasts in the perichondrium, suggested that loss of c-Myc might
Figure 3. Delayed endochondral ossification and suppressed bone growth caused by c-Myc deficiency. Alcian blue and Alizarin red
stained forelimb and hindlimb skeletal preparations at E15.5 (A) and E18.5 (C). Arrows point to primary ossification centers of the humerus and femur
to indicate delayed (E15.5) and smaller (E18.5) ossification centers in c-Myc deficient limbs. (B, D) Alcian blue and hemotoxylin and eosin (H&E) stained
sections at E15.5 and E16.5. Bars indicate length of primary ossification center. (E) Alizarin red stained tibia at P7 showing small, but fully ossified bone
in c-Myc mutants. (F) Measurement of bone length at E18.5. Autopod length was from the tip of digit 3 to the base of the lunate carpal bone.
doi:10.1371/journal.pone.0018795.g003
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chondrocytes and osteoblasts. Consistent with this idea, both the
expression domains and expression intensity of IHH, Ptch-1 and
PTHrPR were markedly reduced in the absence of c-Myc (Fig. 6A-
D’). In addition, expression of Fgfr3, which is expressed primarily
in the proliferative zone but is a negative regulator of
chondrocyte proliferation [35], was also reduced (Fig. 6E,E’).
Thus, like Runx2, Sox9 and Vegfa, each of these genes was
expressed in the appropriate location within the growth plate and
perichondrium (where applicable), but their expression levels
appeared reduced.
Although the above results raised the possibility that a general
reduction in gene transcription might be an important mechanism
underlying the effect of c-Myc deficiency on skeletogenesis, it was
unclear how much the observed reduction in mRNA signals was
related to decreased number/density of chondrocytes and osteo-
blasts. To address this issue we examined expression of Serine 5
phosphorylation of the C-terminal tail (pCTD) of RNA Polymerase
Figure 4. Control of cell proliferation and cell density in the growth plate by c-Myc. (A) BrdU labeling of control and Prx1-Cre c-Myc mutant
proximal tibia at E16.5. Approximate locations of specific regions of the growth plate (GP) and perichondrium (Pc) are indicated and higher
magnification images for the RZ (yellow dashed box) and PZ (red dashed box) are shown at right. The division between cartilage and perichondrium in
(A) is marked by the black dashedline. Arrow point to articular regions that show reduced proliferation in c-Myc mutants. (B) Percentage of BrdU labeled
cells in comparable regions of the RZ, PZ and perichondrium (Pc) of Prx1-Cre control (c) tibias and Prx1-Cre c-Myc mutant tibias (see Materials and
Methods for details). C) Proximal tibias of the indicated stains at E16.5 stained for Col2a1 and DAPI. Higher magnification views are at right. (D) Proximal
tibias stained for ColX and DAPI with higher magnification views at right. (E) The percentage change in cell density (cells per unit area) of c-Myc mutants
compared to controls in comparable regions of PZ and HZ as determined from sections stained with DAPI alone (see Materials and Methods). *p,0.01.
doi:10.1371/journal.pone.0018795.g004
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Interestingly, pCTD was found to be robust in the proliferative
compartment of the growth plate and appeared to closely match the
c-Myc expression domain (Fig. 6F). Moreover, pCTD was
remarkably low in the equivalent compartment of growth plates
lacking c-Myc (Fig. 6G). Although less robust in perichondrium
relative to the proliferative zone of the growth plate of control Prx1-
Cre mice, pCTD was also clearly reduced in c-Myc deficient
perichondrium (Fig. 6F, G). These results support previous data
suggesting that loss of c-Myc affects global transcription in vivo
[36,24], and suggest that suppression of global transcription, and
not altered transcriptional regulation of any specific set of Myc
target genes, may be ultimately responsible for the effects of c-Myc
loss on endochondral ossification and bone size.
Figure 5. Disrupted endochondral ossification in c-Myc mutants is linked to decreased numbers of osteoblasts and poor
vascularization. (A) Combined ColXa1 immunohistochemistry and Col1 in situ hybridization at E18.5 showing a smaller hypertrophy zone (marked
by ColXa1 – green) and reduced Col1 (dark staining) in the perichondrium of c-Myc mutant tibia. (B) Higher magnification view of the primary
ossification center and adjacent perichondrium showing fewer Col1-positive osteoblasts (orange arrow) and a thinner Col1-positive layer in the
perichondrium of c-Myc mutant tibia. Red staining is pan-cytokeratin. (C) Runx2 in situ hybridization. (D) Vegfa in situ hybridization showing reduced
expression in hypertrophic chondrocytes of c-Myc mutant tibia at E18.5. Approximate locations of proliferative and prehypertrophic zones are
indicated and higher magnification images of boxed regions are shown at right. (E) PECAM immunohistochemistry indicating reduced vascularization
of the primary ossification center and perichondrium of c-Myc deficient tibia. Red boxed area is shown at higher magnification on right. (F) TUNEL
staining for apoptotic cells at the ossification fronts of control and c-Myc mutant tibia.
doi:10.1371/journal.pone.0018795.g005
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mesenchyme causes defects in limb bud outgrowth that
can be attributed to deletion of N-Myc
N-Myc supports proliferation of undifferentiated mesenchymal
cells in the limb bud and therefore contributes to the generation of
Sox9-positive cells of the limb bud core that form the precartila-
ginous condensation [25,3]. In contrast to N-Myc deletion, which
consistent to previous results caused a strong decrease in BrdU
incorporation in limb bud mesenchyme (but not in ectoderm) at
E10.5, Prx1-Cre deletion of c-Myc had little or no effect on
mesenchyme proliferation at this stage (Fig. 7IA–C, also see
Fig. 1H). These effects on proliferation are consistent with the
different expression patterns of N-Myc and c-Myc in the early limb
bud (Fig. 1A–D, [25,3]. Similar to these differential effects on
BrdU incorporation, pCTD was strongly diminished in the
mesenchyme of N-Myc and dcko mutants, but not in c-Myc mutants
(Fig. 7IIA–D’). Note that pCTD levels in the ectoderm serves as a
control because Prx1-Cre is not active in the ectoderm.
Whereas deletion of N-Myc by Prx1-Cre caused formation of small
misshapen limb buds and subsequently small skeletal elements and
syndactyly [25], loss of c-Myc had little or no consistent effect on limb
bud size and shape (Fig. 7IB, IIIB), but affected the initial expression
of Sox9 and Runx2 at limb bud stages (Fig. 2A’, 7IVJ, N) and resulted
in small skeletal elements as described above. In contrast, N-Myc
deletion suppressed the initial Sox9 and Runx2 expression at E10.5
and E11.5 respectively (Fig. 7IVC, N) and more severely affected
limb bud development, causing smaller and narrower forelimb and
hindlimb buds (Fig. 7IIIC and [25]. N-Myc deficient forelimb buds
were more severely affected than hindlimb buds (Fig. 7IIIC), a result
in line with the more robust Prx1-Cre activity in the emerging
forelimb bud than in the hindlimb bud [31]. Consistent with N-Myc
regulating early undifferentiated limb bud mesenchyme and limb
bud outgrowth and c-Myc acting primarily at later stages, combined
deletion of N-Myc and c-Myc with Prx1-Cre (dcko), like deletion of N-
Myc alone, resulted in strongly reduced cell proliferation and
produced small limb buds at E10.5 (Fig. 7IC, D). Similarly, N-Myc
deficient limb buds at E12.5 exhibited the characteristic shape and
reduced size of dcko limb buds, with forelimb buds being more
severely affected (Fig. 7IIIC, D and data not shown).
The small size of dcko limb buds was not due to any substantial
defects in expression of Fgf8 in the apical ectodermal ridge or Sonic
hedgehog (Shh) in the zone of polarizing activity (Fig. 7IVA–H).
Thus, defects in limb bud growth of dcko mice occurred
downstream or parallel to the activities of the major limb bud
signaling centers regulating proximal-distal and anterior-posterior
limb development. The upregulation of Sox9 at E10.5 caused by c-
Myc deletion alone did not occur when N-Myc was also deleted or
in dcko mutants (Fig. 7IVK, L and also see Fig. 2B’), and the initial
Runx2 expression domain in the limb bud was reduced in N-Myc
and dcko mutant limb buds at E11.5 Fig. 7IVO, P). These results
are consistent with a requirement for N-Myc in the efficient
production of cells that will become Sox9 and Runx2 expressing
osteo-chondro progenitors prior to c-Myc expression in these cells
or their derivatives.
Combined loss of N-Myc and c-Myc in limb bud
mesenchyme causes severe skeletal hypoplasia and loss
of proximal elements
While N-Myc and c-Myc have unique and mostly complementary
expression patterns in the developing limb, the initial forelimb
cartilage templates of Prx1-Cre c-Myc and N-Myc mutants at E13.5
exhibited a similar reduction in overall size (Fig. 8A). The forelimb
skeleton of dcko embryos at E13.5 revealed a minimally developed
cartilage template with no evidence of a humerus element or
proximal scapula tissue (Fig. 8A). The hindlimb elements of N-Myc
mutants were not as severely affected as c-Myc mutants, a result
consistent with delayed Prx1-Cre activity in hindlimb buds relative
to forelimb buds (32, Z-QZ and PJH not shown) and the
demonstrated role of N-Myc (but not c-Myc) in proliferation of
limb bud mesenchyme (Fig. 7I). Furthermore, while the E13.5
hindlimb skeleton of dcko embryos was grossly hypoplastic and the
femur, like the humerus in the forelimb was missing (Fig. 8B), they
were less severely affected than dcko forelimbs (Fig. 8A), a result
that again can be attributed to delayed deletion of N-Myc in
hindlimb mesenchyme relative to forelimb. Moreover, PCR
genotyping of E10.5 limb bud mesenchyme showed robust and
essentially equivalent Prx1-Cre mediated deletion of c-Myc and N-
Myc (data not shown), indicating that any differences observed
were not due to differences in ablation efficiency. Taken together
with our analysis of Prx1-Cre and Sox9-Cre c-Myc mutants, these
results are consistent with N-Myc and c-Myc playing distinct and
complementary roles during development of the limb skeleton.
The basic observations of dcko limb skeletons at E13.5 are
reinforced by examination of the skeleton at later stages. At E15.5,
very little can be deciphered from forlimbs of dcko embryos
because they are so poorly developed (Fig. 8C). However, at E18.5
and E20.5, it was clear that forelimbs of dcko embryos lacked a
radius, humerous, and proximal scapula tissue (Fig. 8D, F) and the
hindlimb exhibited a hypoplastic skeleton with poor ossification as
indicated by Alizarin red staining (Fig. 8E, G). In the dcko
hindlimbs, the fibula was absent and the femur was more affected
than the tibia (Fig. 8E, G). The hindlimb girdle was less affected
than the scapula in dcko mice, with the latter being comprised of
only the most proximal component (Fig. 8D). In addition, fusion
between the femur and tibia in dcko hindlimbs was consistently
observed (Fig. 8E, H and not shown). Finally, in the autopod of
dcko forelimbs, only the central digits (typically digits 3 and 4) were
formed, and like N-Myc mutants [25] they exhibited complete
syndactyly with boney fusions (Fig. 8F and data not shown).
Defects in endochondral growth and ossification caused
by combined loss of N-Myc and c-Myc
Both forelimb and hindlimb elements of dcko mice remained
extremely small throughout development and exhibited very small
or no primary ossification centers, suggesting persistent disruption
of endochondral growth and ossification. Because forelimb skeletal
elements that formed in dcko mice were extremely small and
misshapen, we examined endochondral growth and ossification on
less severely affected hindlimb. Histological analysis of E18.5
proximal tibia sections from dcko mice revealed a combination of
architectural features found in individual c-Myc and N-Myc cko
mice (Fig. 9IA,B). First, the epiphyseal head, which encompasses
the resting/progenitor zone of the growth plate, was consistently
reduced in size in both N-Myc mutants and dcko mice, but not in c-
Myc mutants (Fig. 9IA–D – green dashed line). Second, the
characteristic narrow and constricting growth plate from the
proliferating zone to the ossification center of c-Myc mutants was
present in dcko mice, but not in N-Myc mutants (Fig. 9IA–D’).
While chondrocytes in the growth plates of individual Myc dcko
mutants differentiated into ColXa1-positive hypertrophic cells, the
reduced numbers of chondrocytes in the prehypertrophic/
hypertrophic region, particularly in c-Myc mutant and dcko growth
plates, corresponded to markedly reduced levels of Ihh, Runx2,
Vegfa (Fig. 9IIA–L). Moreover, decreased vascularization of the
perichondrium and ossification front correlated with reduced Vegfa
levels in c-Myc and dcko mutants. (Fig. 9IIM–O). As in c-Myc
mutants (Fig.6B), these effects corresponded to severely reduced
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Suppressed pRpCTD at these locations in the hindlimb tissues
analysed is primarily attributed to loss of c-Myc since c-Myc and
not N-Myc is expressed at these sites and relative to Prx1-Cre
deletion of N-Myc in the forelimb (early limb bud deletion), Prx1-
Cre deletion of N-Myc in the hindlimb (late limb bud deletion)
results in a less hypoplastic skeleton.
Finally, whereas N-Myc deficiency alone decreased the size of
the epiphyseal head of the tibia (and other limb elements – not
shown), and resulted in small declines in expression of Ihh, Runx2,
Vegfa in the growth plate, it had a relatively strong effect on Col1
and Runx2 expression in the perichondrium, and on the thickness
of perichondrium (Fig. 9IB, B’, F, 9IIF). c-Myc deficiency also
resulted in a thin perichondrium and reduced perichondrial
expression of Col1 and Runx2 (Fig. 9IC, C’, F, 9IIG). Consistent
with both c-Myc and N-Myc contributing to osteoblast develop-
ment, Col1 and Runx2 were further reduced in dcko mutants, which
had very little identifiable perichondrial tissue (Fig. 9ID, D’,
9IIH,L).
Discussion
In this study we show that c-Myc and N-Myc function
cooperatively to drive limb development. Together with previous
studies on the role of N-Myc in limb development [25,3], our data
support a model in which N-Myc plays an important role in limb
budoutgrowthandproductionofmesenchymalcellsthatgiveriseto
chondrocyte and osteoblast progenitors, while c-Myc participates in
theproliferativeexpansionoftheselattercells(Fig.10).Moreover,c-
Mycappearsto be particularlyimportant inthegrowth plate,where
it controls bone size by regulating the transition of resting
chondrocytes to proliferating chondrocytes and therefore the
ultimate number of cells that become mature chondrocytes.
c-Myc regulation of endochondral growth and
ossification
In many respects, the dynamics of growth plate function and
endochondral ossification resembles that of other homeostatic
tissues such as skin and gut epithelium and the hematopoetic
Figure 7. Combined c-Myc and N-Myc deletion mimics deletion of N-Myc alone in the early limb bud and prevents Sox9 upregulation
caused by c-Myc deletion. (IA–D) BrdU labeling of limb buds at E10.5 for the indicated genotypes. Higher magnification views of boxed areas (red)
are shown in A’–D’. Similar results were observed in sections from three different limb buds. (IIA–D’) pRpCTD immunohistochemistry of E10.5 limb
buds of the indicated genotypes with high (IIIA–D) Comparison of limb size and morphology for the indicated strains at E12.5. (IV) Whole mount in
situ hybridization for Fgf8, Shh and Sox9 at E10.5 and Runx2 at E11.5 in Prx1-Cre, c-Myc cko, N-Myc cko and dcko embryos.
doi:10.1371/journal.pone.0018795.g007
Figure 6. Decreased expression of key regulators of the transition from proliferation to prehypertrophy in chondrocytes in the
absence of c-Myc deletion. (A–E’) In situ hybridization (purple signal) of c-Myc, Fgfr3, IHH, Ptch-1 and PTHrPR in control and c-Myc proximal tibia at
E16.5. Arrows point to perichondrial expression of c-Myc, Ptch-1 and PTHrPR expression. Approximate subregions of the growth plate are indicated. (F,
G) pRpCTD (pCTD) immunohistochemistry of control and Prx1-Cre c-Myc mutant tibias at E16.5. Higher magnification views are shown at right.
Approximate subregions (RZ, PZ and PHZ) of the growth plate are indicated and perichonium (Pc) and growth plate (GP) regions of the higher
magnification are indicated.
doi:10.1371/journal.pone.0018795.g006
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prominent roles in regulating the maintenance and expansion of
resident stem cells as well as their commitment towards more
differentiated cell types. This is probably most apparent in the skin
where c-Myc upregulation is associated with the transition from
slow-dividing keratinocyte stem cells to highly proliferative transit-
amplifier cells, whose multiplication is needed to meet the
requirements of an organ that is continuously sloughing off
terminally differentiated cells [38]. While endochondral bone
growth is finite, the role of c-Myc in producing differentiated
chondrocytes during this process appears to provide an analogous
function. After the initial formation of cartilage, c-Myc promotes
endochondral bone growth by stimulating largely quiescent
chondrocytes within the reserve zone to proliferate in conjunction
Figure 8. Combined c-Myc and N-Myc deletion results in severe limb skeletal agenesis. (A, B) Alcian blue stained forelimbs respectively of
the indicated mouse strains at E13.5. (C) Alcian blue stained c-Myc and dcko mutants at E15.5. (D) Alcian blue and Alizarin red stained preparation of
E18.5 embryos showing forelimbs (yellow arrow points to the absence of humerus and distal scapula). (E) E18.5 hindlimb region with higher
magnification image at right showing fusion of the femur (f)-tibia (t) joint (*) of dcko embryos. (F) Forelimbs of E20.5 embryos showing absence of
humerus and scapula elements in dcko embryos. (G) Hindlimbs of c-Myc and dcko mutants at E20.5. (H) Higher magnification images of the femur-
tibia joint region of the E20.5 dcko mutant shown in (G).
doi:10.1371/journal.pone.0018795.g008
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PLoS ONE | www.plosone.org 11 April 2011 | Volume 6 | Issue 4 | e18795Figure9. Unique and additive contributions of N-Myc and c-Myc to endochondral growth and ossification. (IA–D’) Histological comparison
of E18.8 proximal tibia of N-Myc, c-Myc and dcko mutant embryos. Green dashed lines outline the epiphyseal head regions and higher magnification
views of the black-boxed regions are shown (A’–D’). Arrow in dcko image (D) indicates fusion between tibia/fibula and femur. (E–H) Combined ColXa1
immunohistochemistry (green) and Col1 in situ hybridization (dark blue) at E18.5. (II) In situ hybridization of Ihh (A–D), Runx2 (E–H) and Vegfa (I–L) and
PECAM immunohistochemistry (M–P) in tibia sections at E18.5 from the indicated mouse strains. Yellow boxed regions in M-P are shown in M’–P’.
doi:10.1371/journal.pone.0018795.g009
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program. As a result, c-Myc appears to alter the architecture of
the growth plate and control endochondral ossification and the
ultimate size of bones by regulating the number of terminally
differentiated chondrocytes produced. While the detailed mech-
anism by which c-Myc regulates chondrocyte proliferation
remains unclear, we show that transcription initiation by RNA
PolII, as marked by phosphorylation of its CTD, is strongly
upregulated in proliferating chondrocytes where c-Myc is expressed
(Fig. 6B, Fig. S3). Moreover, the failure of pCTD to be
upregulated and an apparent reduction in expression of various
important regulators of growth plate function in the absence of c-
Myc is consistent with the notion that Myc broadly affects the
transcriptional state of cells and that a Myc-induced hypertran-
scriptional state is associated with, and perhaps necessary for,
stimulating and maintaining high levels of cell proliferation [36].
Moreover, the striking reduction in pCTD in limb bud
mesenchyme of Prx1-Cre N-Myc mutants suggests that N-Myc
and c-Myc have the same general effect on global gene
transcription.
While c-Myc promotes chondrocyte proliferation in the growth
plate, our data indicate that it also influences proliferation in the
perichondrium and is required for efficient production of
osteoblasts. c-Myc is expressed in a ring pattern around the core
of the limb bud at E11.5 and in perichondrium of cartilage
anlagen at E13.5 (Fig. 1D), locations where osteoblast progenitors
are thought to first arise and expand in number respectively
[5,21]. Moreover, perichondrial c-Myc expression at E16.5 appears
to overlap with expression of Ptch-1 and Pthr1 (Fig. 6A), which are
well-established regulators of osteoblast proliferation [7,8]. How-
ever the finding that Osx1-Cre deletion of c-Myc resulted in no
discernable skeletal phenotype (Fig. S2 and data not shown),
suggests that any cell autonomous role of c-Myc in osteoblast
proliferation and behavior must take place prior to Osx1-related
activities that are involved in osteoblast differentiation [8]. Indeed,
the finding that c-Myc is upregulated and proliferation is induced
in osteoblasts upon deletion of Osx1 [39] supports the idea that
Osx1 functions at post-mitotic stages in the osteoblast differenti-
ation program at least in part by suppressing c-Myc expression.
Although our results implicate c-Myc in the control of osteoblast
development, a potential cell non-autonomous role for c-Myc in
regulating osteoblast proliferation and behavior may be linked to
its control of chondrocyte proliferation and the number of
differentiated chondrocytes produced in the growth plate. This is
because the transition from proliferating chondrocytes to pre-
hypertrophic chondrocytes coincides with expression of factors
such as Runx2, Vegfa, and Ihh, whose activities help coordinate
chondrocyte proliferation and differentiation during endochondral
ossification [8]. Whereas Ihh influences chondrocyte proliferation
and osteoblast proliferation and/or survival through binding its
receptor Ptch-1 in the growth plate and perichondrium respec-
tively, Vegfa stimulates vascularization of the cartilage template
and hence migration of osteoblasts to the ossification front [8].
Since Ihh plays an important role in maintaining chondrocyte
proliferation, the reduced number of Ihh producing prehyper-
trophic chondrocytes in c-Myc mutants and the apparent reduction
Figure 10. Model for the combined actions of N-Myc and c-Myc during limb development. N-Myc expression in the early limb bud
promotes expansion of undifferentiated multipotent mesenchymal cells. As the limb bud expands, secreted factors from the ectoderm (e.g. FGF and
Wnt family members) that promote N-Myc expression and proliferation in underlying mesenchyme can no longer reach the most central cells and
these cells exit the cell cycle and are fated to become Sox9-positive chondro-osteoprogenitors [3]. In addition to cell cycle exit, the hypoxic
environment and Hif1a upregulation [44] appears to participate in fate determination steps that initiate the Sox9-positive chondrocyte and Runx2-
positive osteoblast lineages. The commencement of low-level c-Myc expression in these lineages is proposed to promote their proliferative
expansion, but maintain their multipotent progenitor character. Subsequent elaboration of the growth plate in cartilage anlagen leads to the
regional partitioning of c-Myc expression where it acts as part of a program to mobilize resting chondrocytes to proliferate and commit to the
chondrocyte terminal differentiation program. Although c-Myc expression in perichondrial osteoblasts likely contributes to their proliferation, by
controlling the number of hypertrophic chondrocytes produced, c-Myc impinges on the production of critica l factors produced from these cells that
also promotes osteoblast development and endochondral ossification.
doi:10.1371/journal.pone.0018795.g010
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predicted to further diminish both chondrocyte and osteoblast
proliferation. Indeed, it is possible that Ihh requires c-Myc to
promote or maintain chondrocyte proliferation and the produc-
tion of an appropriate number of prehypertrophic chondrocytes
expressing Ihh, as well as Runx2, Vegfa and other factors that play
critical roles in endochondral growth and ossification. The
production of fewer prehypertrophic chondrocytes in the absence
of c-Myc may therefore be responsible for a cascade of secondary
events that both further reduce the number of chondrocytes and
osteoblasts in developing bones and diminish the ability of those
produced to participate in endochondral ossification.
Coordination of limb skeletal development through
sequential N-Myc and c-Myc expression
The role of N-Myc in limb skeletal development appears to
primarily be involved in promoting the expansion of undifferen-
tiated mesenchymal cells in the limb bud that will contribute to
formation of the precartilaginous condensation from which
chondro-osteoprogenitors develop [25,3]. Results shown here
suggest that the activities are related to global effects on initiation
of gene transcription (Fig. 7IIC,D). However, N-Myc may not
have a uniform effect on condensation formation or chondro-
osteoprogenitors since its deletion has a preferential effect on
proximal elements, which was particularly evident in the dcko mice
(Fig. 7V, VI, Fig. 8). Interestingly, N-Myc expression is fairly
uniform in distal limb bud mesenchyme as the limb bud emerges,
but then develops a strong lateral bias around E11.5 [25]. Thus,
the relatively strong affect N-Myc deficiency has on the
development of proximal elements may reflect a role for N-Myc
in sustaining the production of cells that preferentially contribute
to the prospective proximal region of the nascent condensation.
Since retinoic acid signaling controls formation of the proximal
limb skeletal elements [2], N-Myc may be involved in either
regulating or mediating retinoic signaling in this setting. Further
characterization of proximal limb development and segmentation
in N-Myc and dcko mutants may help illuminate a potential role for
N-Myc in retinoic acid signaling and how undifferentiated
mesenchyme contributes to the regional specification and growth
of the developing limb skeleton.
Genetic swap experiments indicate that N-Myc and c-Myc are
functionally redundant during development [40], raising the
question of why there is a transition from N-Myc expression in
undifferentiated limb bud mesenchyme to c-Myc expression in
chondrocyte and osteoblast lineages? In the developing limb, this
transition coincides with a shift from highly proliferative
undifferentiated mesenchyme that strongly express N-Myc, to the
largely non-proliferative precartilaginous condensation at the core
of the limb bud where N-Myc is no longer expressed [25,3] and
where c-Myc expression appears to surround (Fig. 1B, H).
Therefore, one possibility is that the absence of both N-Myc and
c-Myc proteins in the central core of the limb bud and a
concomitant exit from the cell cycle of its residents serves as part of
a mechanism that leads to the development of chondrocyte and
osteoblast lineages. Consistent with this idea, preliminary data
from mice in which ectopic c-Myc expression was targeted
specifically to Sox9-expressing cells of the precartilaginous
condensation show poor formation of the early cartilage template
and defects in endochondral ossification that leads to short skeletal
elements (Z-Q.Z, C-Y.S and P.J.H., unpublished). Thus, given the
well-established role of Myc in promoting and maintaining the
pluripotent or multipotent character of stem and progenitor
populations and the ability of forced Myc expression to suppress
cell fate transitions and cell differentiation [24,23,41], a transient
period of low/no Myc expression and associated cell cycle exit
may facilitate epigenetic reprogramming events and related
changes in gene expression required for promoting and/or fixing
new cell fates, including expression of Sox9 and development of
chondro-osteoprogenitors in condensing mesenchyme of the limb
bud. Interestingly, even though either N-Myc or c-Myc are
expressed in most if not all proliferating cell types [42,27], they
are rarely expressed in the same cells and switching from
expression of one Myc gene to another appears to be a common
event associated with various developmental transitions during
organogenesis and in homeostatic tissues [37]. Thus, while
providing essentially the same activity, the unique (but potentially
partially overlapping) transcriptional codes of N-Myc and c-Myc
may have evolved to facilitate and coordinate developmental
transitions that incorporate, and presumably require, a transient
exit from the cell cycle. Understanding these codes may provide
insight not only into the underlying mechanisms that drive various
critical developmental transitions, but also into how to manipulate
the expression of Myc proteins in vivo to facilitate the therapeutic
proliferative expansion of specific progenitor populations in injury
and disease settings.
Materials and Methods
Mice
c-Myc-floxed mice [30] were mated with Prx1-Cre mice (Logan
et al. 2002), Osx1 -Cre mice [33] and Sox9-Cre [5] on a mixed
background of C57BL/6 and 129. c-Myc-floxed mice were mated
with N-Myc-floxed mice [43] and Prx1-Cre mice to generate double
conditional knockout mice. All mice were maintained and used in
accordance with animal protocols approved by the Oregon Health
& Science University Institutional Animal Care and Use
Committee.
Histological analysis
Alcian blue, Alizarin red staining and von Kossa staining were
performed using standard procedures. To examine detailed bone
architecture (Fig. 8A–D), limbs were fixed with 1.5% glutaralde-
hyde/1.5 paraformaldehyde in DMEM w/0.6% Ruthenium
hexamine trichloride overnight at 4 degrees followed by 3 changes
of DMEM containing 0.6% RHT over 15 minutes. Tibias were
dissected out, osmicated for 90 min in 1% OsO4 w/0.6% RHT in
DMEM, rinsed in DMEM, dehydrated from 30 to 100% EtOH,
rinsed in propylene oxide and infiltrated in Spurr’s epoxy
(microwave assisted). Samples were cut and stained using the
epoxy tissue stain from EMS (Charleston SC).
Immunohistochemistry and in situ hybridization
Embryos were fixed in 4% paraformaldehyde at 4uC overnight
and processed for whole mount in situ hybridization using
digoxigenin-UTP-labeled probes or embedded in OTC and
sectioned before hybridization as previously described (Brent
et al. 2003). For immunohistochemistry, limb sections were
incubated with the following primary antibodies: anti-phospho-
Rpb1 CTD - Cell Signaling, Danvers, MA, anti-CD31(PECAM) -
BD Bioscience, San Jose, CA, Type X collagen - Dr. William
Horton), followed by incubations with Alexa Flour-conjugated
secondary antibodies (Invitrogen, Carlsbad, CA) or DAB staining
using the Vectastain ABC Kit (Vector Laboratories, (Burlingame
CA) as previously described [25].
BrdU incorporation and TUNEL assays
BrdU (Sigma) labeling (1.5 hr) was performed using BD
Biosciences (San Jose, CA) BrdU In Situ Detection Kit as
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counterstained with Hematoxylin. TUNEL was performed on
fixed sections using the Roche (Basal, Switzerland) In Situ Cell
Death Detection Kit. The percentage of BrdU positive cells was
determined from counts of total cell numbers within comparable
regions of sectioned limb buds or proximal tibia. Counts were
determined from at least three serial sections from two or more
independent experiments. Data are presented as mean 6 SEM.
Statistical significance of differences was calculated using Student’s
t-test.
Cell density measurements
Cell density measurements were made from within equivalent
areas of proliferative and hypertrophic zones. The specific regions
selected were identified by their characteristic cell morphology, as
well as by BrdU labeling of serial sections and ColX staining.
DAPI stained sections from at least five different tibias were used
in these calculations. Data are presented as mean 6 SEM and
statistical significance of differences were calculated using
Student’s t-test.
Supporting Information
Figure S1 Limb skeletal phenotype of mice with Sox9-
Cre deletion of c-Myc. (A) Alcian blue/Alizarin red staining of
forelimb skeletal elements at E15.5 and (B) Alcian blue and H&E
staining of E15.5 proximal tibia sections. Comparison of Alcian
blue/Alizarin red staining of forelimb skeletal elements at E18.5 of
the indicated mouse strains is shown.
(TIFF)
Figure S2 Osx1-Cre deletion of c-Myc has little or no
effect on endochondral ossification and growth. (A) Alcian
blue and Alizarin red skeletal preparations of the indicated mice at
E18.5 mice. (B) Isolated hindlimbs E18.5 mice. (C) Alcian blue and
H&E staining of proximal tibia sections.
(TIFF)
Figure S3 Immunohistochemical analysis of RNA Poly-
merase CTD phosphorylation in E18.5 tibias of the
indicated mouse strains. Approximate locations of the
Resting (RZ), Proliferative (PZ), Prehypertrophic (PHZ) and
Hypertrophic Zones (HZ) are shown. Higher magnification
images of the boxed regions are shown on the right.
(TIFF)
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